Borer Denton & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.24M | Sell |
104,941
-3,392
| -3% | -$234K | 2.51% | 18 |
|
|
2025
Q1 | $7.52M | Sell |
108,333
-4,848
| -4% | -$337K | 2.66% | 16 |
|
|
2024
Q4 | $9.74M | Sell |
113,181
-1,291
| -1% | -$111K | 3.39% | 10 |
|
|
2024
Q3 | $13.6M | Sell |
114,472
-750
| -0.7% | -$89.3K | 4.65% | 6 |
|
|
2024
Q2 | $16.4M | Sell |
115,222
-800
| -0.7% | -$114K | 5.97% | 4 |
|
|
2024
Q1 | $14.9M | Sell |
116,022
-200
| -0.2% | -$25.7K | 5.27% | 4 |
|
|
2023
Q4 | $12M | Sell |
116,222
-300
| -0.3% | -$31K | 4.6% | 6 |
|
|
2023
Q3 | $10.6M | Sell |
116,522
-100
| -0.1% | -$9.09K | 4.38% | 6 |
|
|
2023
Q2 | $9.44M | Hold |
116,622
| – | – | 3.72% | 10 |
|
|
2023
Q1 | $9.28M | Buy |
116,622
+6,970
| +6% | +$555K | 3.85% | 10 |
|
|
2022
Q4 | $7.42M | Hold |
109,652
| – | – | 3.29% | 14 |
|
|
2022
Q3 | $5.46M | Buy |
109,652
+3,580
| +3% | +$178K | 2.72% | 17 |
|
|
2022
Q2 | $5.91M | Buy |
106,072
+150
| +0.1% | +$8.36K | 2.85% | 17 |
|
|
2022
Q1 | $5.88M | Buy |
+105,922
| New | +$5.88M | 2.47% | 17 |
|